UNSPSC 51442716: Technetium Tc-99m sestamibi or technetium 99mtc sestamibi

This classification denotes a radioconjugate with the molecular formula C36H66N6O6TC, a contrast medium that practitioners use in myocardial perfusion studies, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 971Z4W1S09, more generally known as Technetium Tc-99m sestamibi. The European Medicines Agency schedules Technetium Tc 99m sestamibi in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10857MIG. The term Technetium Tc 99m SESTAMIBI is an International Non-Proprietary Name or INN.

Most nations schedule Technetium Tc-99m sestamibi or technetium 99mtc sestamibi under HS 28444030.

UNSPSC 51442716 Technetium Tc-99m sestamibi is a Commodity code that nominally identifies a radiopharmaceutical diagnostic agent, yet the recent state and local opportunities posted under this code show no alignment with that scope. The two recent solicitations — one from Broward County Aviation Department seeking maintenance services for Rapiscan X-ray inspection systems, and one from Pasco County seeking copper sulfate crystals and liquid copper sulfate — are unrelated to technetium-based medical imaging or nuclear medicine procurement. The mismatch suggests either a cataloging error in the state and local systems tagging these opportunities, or a significant divergence between the code's intended use and current practice at these issuing bodies. No recent opportunities appear to solicit the radiopharmaceutical agent the code nominally describes.

The code shows minimal relevant activity from the state and local market as currently visible. Without additional opportunities properly tagged to this Commodity code, the geographic spread and concentration of genuine technetium Tc-99m sestamibi procurement cannot be characterized from this source. Business development professionals evaluating this code should verify whether state and local agencies—particularly health departments, hospital systems, and medical research institutions—use a different UNSPSC classification for radiopharmaceutical procurement, or whether opportunities in this market operate through federal health programs or cooperative purchasing vehicles that do not post under state and local notice systems in the dataset.